KENS 5: Breakthrough drug in the battle against Alzheimer’s

September 6, 2016

More than 5 million Americans suffer from Alzheimer’s disease, an illness first discovered more than 100 years ago. Now researchers say that there is a possible breakthrough in the battle against the debilitating disease. Watch the full story at KENS 5

Alzheimer's Disease


Community invited to participate in national health care improvement conference

August 23, 2016

San Antonio area residents will have the opportunity to contribute to improving patient safety and the quality of health care at a national conference sponsored by the School of Nursing of the UT Health Science Center San Antonio. The “Conference on Community Engagement and Healthcare Improvement” will take place Friday, Saturday and Sunday, Sept. 2-4, at the Wyndham San Antonio Riverwalk hotel, 111 E. Pecan, in downtown San Antonio.

Hispanic child eating healty


Science Daily: Brain cell death in Alzheimer’s linked to structural flaw

July 14, 2016

Researchers found that the nuclei from brain cells of patients with Alzheimer’s disease contained tunnels (arrows) not found in normal brain cells. “We have identified multiple new cellular processes that go awry in Alzheimer’s disease because of pathological tau,” said Bess Frost, Ph.D., assistant professor, Barshop Institute for Longevity and Aging Studies.

Alzheimer's Disease


U.S. News & World Report: This old drug could boost your memory

July 5, 2016

A long-used drug called methylene blue may rev up activity in brain regions involved in short-term memory and attention, a small study suggests. Methylene blue has been used in medicine for more than a century, said Timothy Duong, the senior researcher on the study and a professor at the University of Texas Health Science Center at San Antonio.




Austrian Tribune: APOE Variant Might Have Adverse Impact During Childhood

July 1, 2016

According to a new cross-sectional research, children detected with the e4e4 and e2e4 variant of the apolipoprotein E (APOE) gene displayed smaller hippocampal volumes and inferior cognitive assessment performance, as compared to children with other variants of APOE gene. Read the full story at the Austrian Tribune